Figure 3From: Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapyDisplay of the concentration - response curves for the individual gastric cancer samples and the indicated drugs. Considerably inter-individual variability is observed. Curve adaption based on observed data points was made in the GraphPad Prism software. Number of samples investigated was 16 for 5-FU and irinotecan and 15 for cisplatin and docetaxel.Back to article page